Related Experiment Video
Updated: Aug 30, 2026

Analysis of the c-KIT Ligand Promoter Using Chromatin Immunoprecipitation
Published on: June 27, 2017
Tumor necrosis factor-alpha-converting enzyme controls surface expression of c-Kit and survival of embryonic stem
Anthony C Cruz1, Brendon T Frank, Samuel T Edwards
1Cardiovascular Research Institute, University of California, San Francisco, California 94143, USA.
Abstract:
Transmembrane metalloproteinases of the disintegrin and metalloproteinase (ADAM) family control cell signaling interactions via hydrolysis of protein extracellular domains. Prior work has shown that the receptor tyrosine kinase, c-Kit (CD117), is essential for mast cell survival and that serum levels of c-Kit increase in proliferative mast cell disorders, suggesting the existence of c-Kit shedding pathways in mast cells. In the present work, we report that tumor necrosis factor alpha-converting enzyme (TACE; ADAM-17) mediates shedding of c-Kit. Stimulation of transfected cells with phorbol 12-myristate 13-acetate (PMA) induced metalloproteinase-mediated release of c-Kit ectodomain, which increased further upon TACE overexpression. By contrast, TACE-deficient fibroblasts did not demonstrate inducible release, thus identifying TACE as the metalloproteinase primarily responsible for PMA-induced c-Kit shedding. Surface expression of c-Kit by the human mast cell-1 line decreased upon phorbol-induced shedding, which involved metalloproteinase activity susceptible to inhibition by tissue inhibitor of metalloproteinase (TIMP)-3. To further explore the role of TACE in shedding of c-Kit from mast cells, we compared the behavior of mast cells derived from murine embryonic stem cells. In these studies, PMA decreased surface c-Kit levels on mast cells expressing wild-type (+/+) TACE but not on those expressing an inactive mutant (DeltaZn/DeltaZn), confirming the role of TACE in PMA-induced c-Kit shedding. Compared with TACE(+/+) cells, TACE(DeltaZn/DeltaZn) mast cells also demonstrated decreased constitutive shedding and increased basal surface expression of c-Kit, with diminished apoptosis in response to c-Kit ligand deprivation. These data suggest that TACE controls mast cell survival by regulating shedding and surface expression of c-Kit.
Insights
Tumor necrosis factor alpha-converting enzyme (TACE) sheds the c-Kit receptor, impacting mast cell survival. This TACE-mediated shedding regulates c-Kit levels and influences mast cell apoptosis.
Area of Science:
- Biochemistry
- Cell Biology
- Immunology
Background:
- Disintegrins and metalloproteinases (ADAMs) regulate cell signaling through protein hydrolysis.
- The receptor tyrosine kinase c-Kit (CD117) is crucial for mast cell survival.
- Elevated serum c-Kit levels in mast cell disorders suggest shedding mechanisms.
Purpose of the Study:
- To identify the metalloproteinase responsible for c-Kit shedding in mast cells.
- To investigate the role of TACE (ADAM-17) in c-Kit ectodomain release.
- To determine how TACE-mediated c-Kit shedding affects mast cell survival.
Main Methods:
- Stimulation of transfected cells and mast cells with phorbol 12-myristate 13-acetate (PMA).
- Overexpression and deficiency studies using TACE.
- Analysis of surface c-Kit expression and apoptosis in wild-type and mutant TACE mast cells.
Main Results:
- PMA induced c-Kit ectodomain release, enhanced by TACE overexpression.
- TACE-deficient fibroblasts showed no inducible c-Kit release.
- PMA decreased surface c-Kit in wild-type TACE mast cells but not in TACE-deficient cells.
- TACE-deficient mast cells exhibited reduced constitutive shedding and increased basal c-Kit, with diminished apoptosis.
Conclusions:
- TACE (ADAM-17) is the primary metalloproteinase mediating PMA-induced c-Kit shedding.
- TACE regulates mast cell survival by controlling c-Kit shedding and surface expression.
- Targeting TACE may offer therapeutic strategies for mast cell disorders.
More Related Videos
06:16Generation of Orthotopic Pancreatic Tumors and Ex vivo Characterization of Tumor-Infiltrating T Cell Cytotoxicity
Published on: December 7, 2019
06:25Ex Vivo Culture of Circulating Tumor Cells in the Cerebral Spinal Fluid from Melanoma Patients to Study Melanoma-Associated Leptomeningeal Disease
Published on: March 29, 2024
Related Concept Videos
The Tumor Microenvironment
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Mesenchymal Stem Cells
Enzyme-linked Receptors
Regulation of Angiogenesis and Blood Supply
TGF - β Signaling Pathway